Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    MAKTEK Eurasia 2026 to connect MENA buyers with advanced manufacturing

    August 20, 2026

    Next Level Aviation® Appoints Mike Fleener as Senior Vice President of Global Sales

    August 19, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Wall Street rises after Treasury expands debt buybacks
    • MAKTEK Eurasia 2026 to connect MENA buyers with advanced manufacturing
    • Next Level Aviation® Appoints Mike Fleener as Senior Vice President of Global Sales
    • WHO maps three-month path for Congo Ebola containment
    • Indonesia 6.1 earthquake rattles North Sumatra coast
    • DRC Ebola outbreak sets national death toll record
    • DRC malaria cases surpass 26 million in 2025
    • XCMG Accelerates Global Equipment Deliveries for Infrastructure and Mining Projects
    Maghreb DigestMaghreb Digest
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Maghreb DigestMaghreb Digest
    Home » WHO maps three-month path for Congo Ebola containment
    Health

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email

    BUNIA, DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – The World Health Organization says Congo’s Ebola outbreak can still be contained within three months if response teams receive enough resources. The latest official report recorded 5,021 confirmed cases and 2,378 deaths through Aug. 16. Cases now span 55 health zones across six provinces, while the case fatality ratio has reached 47.4%. The toll makes this the deadliest Ebola outbreak in the country’s history. It is also the second-largest Ebola epidemic recorded globally.

    WHO maps three-month path for Congo Ebola containment
    Congo Ebola response expands as health teams work to curb Bundibugyo transmission. (AI-generated image)

    WHO incident manager Thierno Baldé said the three-month timeline depends on securing the resources required for the response. The agency has received about $69.3 million of the $115 million it says it needs, or roughly 60%. Teams added more than 400 treatment beds during the past two weeks. They also deployed 100 additional epidemiologists and more than 500 community health workers for surveillance and contact tracing. The response requires vehicles, ambulances, medical supplies and personnel across a growing affected area.

    Transmission has reached Bas-Uélé, making it the sixth affected province. As of Aug. 12, Ituri accounted for 85% of confirmed cases and 79% of reported deaths nationwide. Officials said 70% to 80% of new cases had no known link to existing patients. Health teams are expanding surveillance to identify cases faster and transfer patients into treatment centers. Bas-Uélé’s first confirmed case had traveled from Haut-Uélé before symptoms began on Aug. 4.

    Response expands across affected provinces

    The Democratic Republic of the Congo’s Ministry of Public Health, Hygiene and Social Welfare declared the outbreak on May 15. Laboratory testing in Kinshasa confirmed Bundibugyo virus, a rarer Ebola species first identified in western Uganda in 2007. This is Congo’s 17th recorded Ebola outbreak since the virus was identified in 1976. Uganda has reported 20 confirmed cases and two deaths, with no new case reported there since June 21. Those cases included imported infections and secondary transmission among contacts and health workers.

    Bundibugyo virus disease currently has no licensed vaccine or approved specific treatment. Care therefore focuses on early detection, supportive treatment, infection control, contact tracing and safe burials. Officials are also expanding community outreach where patients may first seek help outside formal health facilities. Response teams have trained local workers and supplied hygiene materials to reduce exposure during transport and body handling. Early supportive care can improve survival for people infected with Bundibugyo virus disease.

    Funding gap remains as surveillance expands

    Contact monitoring has improved but remains below public health targets in several affected areas. On Aug. 12, teams followed 17,460 of 20,740 listed contacts, a national follow-up rate of 84.2%. Health officials have deployed more field epidemiologists to raise detection rates and shorten the time between symptoms and care. They are also using community workers to report suspected cases and connect patients with treatment centers. Officials recorded 155 infections among health workers and 45 deaths by Aug. 9.

    WHO designated the outbreak a Public Health Emergency of International Concern on May 17. National authorities and international partners continue surveillance, laboratory testing, clinical care, safe burials and community engagement. Baldé tied the three-month containment assessment directly to securing the required resources. The latest weekly count included 640 additional confirmed cases and 367 additional confirmed deaths since Aug. 9. The response also continues amid insecurity and attacks on health services in eastern Congo.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    DR Congo Ebola death toll tops 1,900 as cases rise

    August 11, 2026
    Latest News
    Business

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    Healthcare shares strengthen market gains
    Healthcare stocks provided another source of support during Wednesday’s session as several pharmaceutical shares recorded large gains. Moderna shares surged 177%, while Merck advanced 12.6% after the companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene with Keytruda following surgical removal of high-risk melanoma. The combination met its primary endpoint for recurrence-free survival. It also met a key secondary endpoint measuring survival without distant cancer spread.

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    South Korea auto exports reach $6.24 billion in July

    August 14, 2026

    Total solar eclipse crosses Russian Arctic and Europe

    August 13, 2026
    © 2026 Maghreb Digest | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.